Journal for Managed Care & Specialty Pharmacy Issues Research Articles in November 2022 Edition

ALEXANDRIA, Virginia, Oct. 26 -- The Journal for Managed Care and Specialty Pharmacy, a peer-reviewed journal that says it strives to engage and serve professionals in pharmacy, medicine, nursing and related fields to optimize the value of pharmaceutical products and pharmacy services delivered to patients from the Academy of Managed Care Pharmacy, published research articles on the following topics in its November 2022 edition:

Research:

* Health care resource utilization and costs among individuals with vs without Huntington disease in a US population

* Specialty pharmacy turnaround time impediments, facilitators, and good practices

* Trends in add-on medications following metformin monotherapy for type 2 diabetes

* Within-trial economic analysis of resource use from COMET-ICE: A phase 3 clinical trial evaluating sotrovimab for the treatment of patients with COVID-19 at high risk of progression

* Real-world opioid use among patients with migraine enrolled in US commercial insurance and risk factors associated with migraine progression

* Health care costs and utilization prior to diagnosis of antineutrophil cytoplasmic antibody vasculitis in Medicare beneficiaries

* Comparison of real-world clinical and economic outcomes in patients receiving oral anticoagulants: A retrospective claims analysis

* Health care resource utilization and costs associated with atrial fibrillation and rural-urban disparities

The November 2022 edition of the Journal for Managed Care & Specialty Pharmacy can be viewed at https://www.jmcp.org/toc/jmcsp/28/11.